Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders

Drug and Alcohol Dependence

Volumn 118, Issue 2-3, 2011, Pages 408-416

  Peters, Erica N ^a   Nich, Charla ^a   Carroll, Kathleen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis use disorder; Marijuana; Primary outcome; Treatment

Indexed keywords

CANNABIS;

ARTICLE; BEHAVIOR THERAPY; CANNABIS ADDICTION; DRUG WITHDRAWAL; FACTORIAL ANALYSIS; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BEHAVIOR THERAPY; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; TREATMENT OUTCOME;

CANNABIS; CANNABIS SATIVA;

EID: 80955177100     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.04.021     Document Type: Article

References (52)

1. Allen J.P. Measuring outcomes in interventions for alcohol dependence and problem drinking: executive summary of a conference sponsored by the National Institute on Alcohol Abuse and Alcoholism. Alcohol. Clin. Exp. Res. 2003, 27:1657-1660.
2. Anthony J., Warner L., Kessler R. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 1994, 2:244-268.
3. Babor T.F., Longabaugh R., Zweben A., Fuller R.K., Stout R.L., Anton R.F., Randall C.L. Issues in the definition and measurement of drinking outcomes in alcoholism treatment research. J. Stud. Alcohol 1994, (Suppl. 12):101-111.
4. Baker S.M. Twelve Step Facilitation Therapy for Drug Abuse and Dependence 1998, Yale University Professional Development Committee, New Haven, CT.
5. Beck A.T., Ward C.H., Mendelson M. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:461-471.
6. Bentler P.M. Comparative fit indexes in structural models. Psychol. Bull. 1990, 107:238-246.
7. Bollen K.A. Structural Equations with Latent Variables 1989, Wiley, New York, NY.
8. Bryant F.B., Yarnold P.R. Principal-components analysis and exploratory and confirmatory factor analysis. Reading and Understanding Multivariate Statistics 1995, 99-136. American Psychological Association, Washington, DC. L.G. Grimm, P.R. Yarnold (Eds.).
9. Budney A.J., Higgins S.T. A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction 1998, National Institute on Drug Abuse, Rockville, MD.
10. Budney A.J., Higgins S.T., Radonovich K.J., Novy P.L. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J. Consult. Clin. Psychol. 2000, 68:1051-1061.
11. Budney A.J., Moore B.A., Rocha H.L., Higgins S.T. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J. Consult. Clin. Psychol. 2006, 74:307-316.
12. Carpenter K.M., McDowell D., Brooks D.J., Cheng W.Y., Levin F.R. A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am. J. Addict. 2009, 18:53-64.
13. Carroll K.M., Easton C.J., Nich C., Hunkele K.A., Neavins T.M., Sinha R., Ford H.L., Vitolo S.A., Doebrick C.A., Rounsaville B.J. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J. Consult. Clin. Psychol. 2006, 74:955-966.
14. Carroll K.M., Rounsaville B.J. On beyond urine: clinically useful assessment instruments in the treatment of drug dependence. Behav. Res. Ther. 2002, 40:1329-1344.
15. Carroll K.M., Rounsaville B.J., Nich C., Gordon L.T., Wirtz P.W., Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry 1994, 51:989-997.
16. Cohen J. A power primer. Psychol. Bull. 1992, 112:155-159.
17. College on Problems of Drug Dependence, 1999. Consensus statement on evaluation of outcome of pharmacotherapy for substance abuse/dependence. Retrieved from views.vcu.edu/cpdd/reports/nida_cpdd_report.pdf on June 11, 2010.
18. Copeland J., Swift W., Roffman R., Stephens R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J. Subst. Abuse Treat. 2001, 21:55-64.
19. Derogatis L.R. Brief Symptom Inventory: Administration, Scoring, and Procedures Manual 1993, National Computer Systems, Minneapolis, MN.
20. Donovan D.M., Marlatt G.A. Assessment of Addictive Behaviors 2005, The Guilford Press, New York, NY. 2nd ed.
21. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. Am. J. Psychiatry 2008, 165:179-187.
22. Falk D., Wang X.Q., Liu L., Fertig J., Mattson M., Ryan M., Johnson B., Stout R., Litten R.Z. Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials. Alcohol. Clin. Exp. Res. 2010, 34:2022-2034.
23. Higgins S.T., Delany D.D., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., Fenwick J.W. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 1991, 148:1218-1224.
24. Higgins S.T., Wong C.J., Badger G.J., Ogden D.E., Dantona R.L. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J. Consult. Clin. Psychol. 2000, 68:64-72.
25. Hughes J.R., Keely J.P., Niaura R.S., Ossip-Klein D.J., Richmond R.L., Swan G.E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob. Res. 2003, 5:13-25.
26. Jones B., Jarvis P., Lewis J.A., Ebbutt A.F. Trials to assess equivalence: the importance of rigorous methods. Br. Med. J. 1996, 313:36-39.
27. Joreskog K.G., Sorbom D.G. LISREL 7 User's Reference Guide 1989, Scientific Software, Chicago, IL.
28. Kadden R.M., Litt M.D. Searching for treatment outcome measures for use across trials. J. Stud. Alcohol 2004, 65:145-152.
29. Kadden R.M., Litt M.D., Kabela-Cormier E., Petry N.M. Abstinence rates following behavioral treatments for marijuana dependence. Addict. Behav. 2007, 32:1220-1236.
30. Kandel D., Chen K., Warner L.A., Kessler R.C., Grant B. Prevalence and demographic correlates of symptoms of dependence on cigarettes, alcohol, marijuana, and cocaine in the U.S. population. Drug Alcohol Depend. 1997, 44:437-442.
31. Lauer M.S., Collins F.S. Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. JAMA 2010, 303:2182-2183.
32. Levin, F.R., Mariani, J.J., Brooks, D.J., Pavlicova, M., Cheng, W., Nunes, E.V., in press. Dronabinol for the treatment for cannabis dependence: A randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend., doi:10.1016/j.drugalcdep.2010.12.010.
33. Levin F.R., McDowell D., Evans S.M., Nunes E., Akerele E., Donovan S., Vosburg S.K. Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am. J. Addict. 2004, 13:21-32.
34. McKay J.R., Alterman A.I., Cacciola J.S., O'Brien C.P., Koppenhaver J.M., Shepard D.S. Continuing care for cocaine dependence: comprehensive 2-year outcomes. J. Consult. Clin. Psychol. 1999, 67:420-427.
35. McKay J.R., Alterman A.I., Koppenhaver J.M., Mulvaney F.D., Bovasso G.B., Ward K. Continuous, categorical, and time to event cocaine use outcome variables: degree of intercorrelation and sensitivity to treatment group differences. Drug Alcohol Depend. 2001, 62:19-30.
36. McKay J.R., Weiss R.V. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups: preliminary results and methodological issues. Eval. Rev. 2001, 25:113-161.
37. McLellan A.T., Chalk M., Bartlett J. Outcomes, performance, and quality - what's the difference?. J. Subst. Abuse Treat. 2007, 32:331-340.
38. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 1992, 9:199-213.
39. McRae-Clark A.L., Carter R.E., Killeen T.K., Carpenter M.J., Wahlquist A.E., Simpson S.A., Brady K.T. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009, 105:132-138.
40. Mercer D.E., Woody G.E. An Individual Drug Counseling Approach to Treat Cocaine Addiction: The Collaborative Cocaine Treatment Study Model 1999, National Institute on Drug Abuse, Rockville, MD.
41. The Marijuana Treatment Project Research Group Brief treatments for cannabis dependence: findings from a randomized multisite trial. J. Consult. Clin. Psychol. 2004, 72:455-466.
42. Sobell L.C., Sobell M.B. Timeline Followback: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods 1992, 41-72. Humana Press, Totowa, NJ. R.Z. Litten, J. Allen (Eds.).
43. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R., Jacobs G.A. Manual for the State-Trait Anxiety Inventory (Form Y) 1983, Consulting Psychologists Press, Palo Alto, CA.
44. Steinberg K., Roffman R.A., Carroll K.M., McRee B., Babor T.F., Miller M., Kadden R., Duresky D., Stephens R. Brief Counseling for Marijuana Dependence: A Manual for Treating Adults 2005, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD.
45. Stephens R.S., Babor T.F., Kadden R., Miller M., MTP Research Group The Marijuana Treatment Project: rationale, design, and participant characteristics. Addiction 2002, 97:109-124.
46. Stephens R.S., Roffman R.A., Curtin L. Comparison of extended versus brief treatments for marijuana use. J. Consult. Clin. Psychol. 2000, 68:898-908.
47. Stephens R.S., Roffman R.A., Fearer S.A., Williams C., Burke R.S. The Marijuana Check-up: promoting change in ambivalent marijuana users. Addiction 2007, 102:947-957.
48. Stephens R.S., Roffman R.A., Simpson E.E. Treating adult marijuana dependence: a test of the relapse prevention model. J. Consult. Clin. Psychol. 1994, 62:92-99.
49. Stephens R.S., Wertz J.S., Roffman R.A. Predictors of marijuana treatment outcomes: the role of self-efficacy. J. Subst. Abuse 1993, 5:341-354.
50. Substance Abuse and Mental Health Services Administration Treatment episode data set (TEDS) 1995-2005: National Admissions to Substance Abuse Treatment Services 2008, DHHS, Rockville, MD.
51. Substance Abuse and Mental Health Services Administration, 2009. Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD.
52. Vandrey R., Haney M. Pharmacotherapies for cannabis dependence: how close are we?. CNS Drugs 2009, 23:543-553.